Novatek Pharmaceuticals

Manufacturing · Texas, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

3569 Business Center Dr Ste 110, Pearlan...

Phone Number

(877) 662-8351

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Novatek Pharmaceuticals

Novatek Pharmaceuticals specializes in the development of NP-101, a naturally derived immunotherapy from Nigella Sativa, aimed at treating cancers and infectious diseases. The company focuses on enhancing T-cell responses and boosting the immune system while minimizing adverse effects associated with traditional therapies. With a team boasting over 100 years of clinical research experience, Novatek has a strong pharmaceutical pipeline and has conducted significant clinical trials demonstrating the efficacy of NP-101. Their primary clients include patients suffering from various cancers and infectious diseases, as well as healthcare providers seeking innovative treatment options.Explore more
Novatek Pharmaceuticals's Social MediaPopular SearchesNovatek PharmaceuticalsNovatek Pharmaceuticals IncNovatek Therapeutics LLCSIC Code 28,283NAICS Code 32,325Show more

Novatek Pharmaceuticals Org Chart

PhoneEmail
OK
United States flag for contact location.

Chief Operating Officer

PhoneEmail
HB
United States flag for contact location.

Chief Legal Officer

PhoneEmail
PT
United States flag for contact location.

Chief Legal Officer

PhoneEmail
HS
United States flag for contact location.

Chief Legal Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
KH
United States flag for contact location.

Assistant General Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Novatek Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Novatek Pharmaceuticals

Compare insights from companies similar to Novatek Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Novatek Pharmaceuticals

<$5M
51-200
Private
-
2017
OK
Osama KassebChief Operating Officer
$25.9M
51-200
Private
-
2003
BP
Brad PhillipsVice President, Clinical Operations
$17.4M
51-200
Private
-
2000
AK
Alex KimDirector
<$5M
11-50
Private
<$5M
2012
<$5M
11-50
Private
-
2014
AI
Andri IrawanSoftware Development Engineer
<$5M
11-50
Private
<$5M
2006
Joyce LaViscount, Chief Financial Officer at Bexion Pharmaceuticals
Joyce LaViscountChief Financial Officer
<$5M
11-50
Private
-
2012
AI
Anita IlchevaChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Novatek Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Novatek Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Novatek Pharmaceuticals.

Novatek Pharmaceuticals Tech Stack

A closer look at the technologies used by Novatek Pharmaceuticals

Top Manufacturing Companies

Frequently Asked Questions Regarding Novatek Pharmaceuticals

What is Novatek Pharmaceuticals's official website?
Novatek Pharmaceuticals's official website is www.novatekpharmaceuticals.com
What is Novatek Pharmaceuticals's Revenue?
Novatek Pharmaceuticals's revenue is <$5 Million
What is Novatek Pharmaceuticals's SIC code?
Novatek Pharmaceuticals's SIC: 28,283
What is Novatek Pharmaceuticals's NAICS code?
Novatek Pharmaceuticals's NAICS: 32,325
How many employees does Novatek Pharmaceuticals have?
Novatek Pharmaceuticals has 51-200 employees
What industry does Novatek Pharmaceuticals belong to?
Novatek Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Novatek Pharmaceuticals competition?
Novatek Pharmaceuticals top competitors include: Sofpromed, G-treeBNT, Bexion Pharmaceuticals, KCRN Research
What technology does Novatek Pharmaceuticals use?
Some of the popular technologies that Novatek Pharmaceuticals uses are: WooCommerce, WordPress.org, PHP, Microsoft 365
How do I contact Novatek Pharmaceuticals?
Novatek Pharmaceuticals contact info: Phone number: (877) 662-8351 Website: www.novatekpharmaceuticals.com
What does Novatek Pharmaceuticals do?

Novatek Pharmaceuticals specializes in the development of NP-101, a naturally derived immunotherapy from Nigella Sativa, aimed at treating cancers and infectious diseases. The company focuses on enhancing T-cell responses and boosting the immune system while minimizing adverse effects associated with traditional therapies. With a team boasting over... 100 years of clinical research experience, Novatek has a strong pharmaceutical pipeline and has conducted significant clinical trials demonstrating the efficacy of NP-101. Their primary clients include patients suffering from various cancers and infectious diseases, as well as healthcare providers seeking innovative treatment options.Read More

What are Novatek Pharmaceuticals social media links?
Novatek Pharmaceuticals Linkedin page
Is Novatek Pharmaceuticals a public company?
Novatek Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Novatek Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.